<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>AMA Publishing Group: Frontotemporal Dementia Topic Collection</title>
    <link>http://pubs.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Sat, 01 Jun 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Mon, 10 Jun 2013 16:45:12 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@pubs.jamanetwork.com</managingEditor>
    <webMaster>webmaster@pubs.jamanetwork.com</webMaster>
    <item>
      <title> TREM2 , Frontotemporal Dementia–Like Disease, Nasu-Hakola Disease, and Alzheimer Dementia: A Chicken and Egg Problem?</title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1696565</link>
      <pubDate>Sat, 01 Jun 2013 00:00:00 GMT</pubDate>
      <author>Bianchin M, Abujamra A, Izquierdo I. </author>
      <description>&lt;span class="paragraphSection"&gt;We read with great interest the article by Guerreiro et al on the loss of function of the triggering receptor expressed on myeloid cells 2 (TREM2) gene causing Nasu-Hakola disease (NHD) and some frontotemporal dementia (FTD)–like diseases. Recently, TREM2 allele variants were also found to be associated with Alzheimer disease (AD). However, NHD, FTD-like disease, and AD differ enormously regarding the mechanism of disease, clinical aspects, and neuropathological findings. How can these differences be conciliated?&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">70</prism:volume>
      <prism:number xmlns:prism="prism">6</prism:number>
      <prism:startingPage xmlns:prism="prism">805</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">806</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamaneurol.2013.453</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1696565</guid>
    </item>
  </channel>
</rss>